Mavenclad (cladribine) costs

Neurology

Buy Mavenclad (cladribine) Online

• DISEASE INDICATIONS: Multiple Sclerosis
• MANUFACTURER: Merck Serono Europe Limited
• USAGE: Oral
• MEDICINE APPROVED BY:
• European Medical Agency (EMA)
• Food and Drug Administration (FDA)
• Health Canada
• Therapeutic Goods Administration (TGA)
• Medsafe (NZ)

Mavenclad (Cladribine) is a medication indicated for the treatment of relapsing forms of multiple sclerosis (MS). It is used to reduce the frequency of relapses and delay the progression of disability associated with this chronic neurological condition.

Select optionsThis product has multiple variants. The options may be chosen on the product page